1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Penicillin Antibiotics 1.2.3 Cephalosporins 1.2.4 Carbapenem Antibiotics 1.3 Market by Application 1.3.1 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical Companies 1.3.3 Contract Manufacturing Organizations (CMOs) 1.3.4 Contract Development & Manufacturing Organizations (CDMOs) 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Perspective (2016-2027) 2.2 Antibiotics Active Pharmaceutical Ingredient Growth Trends by Regions 2.2.1 Antibiotics Active Pharmaceutical Ingredient Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antibiotics Active Pharmaceutical Ingredient Historic Market Share by Regions (2016-2021) 2.2.3 Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Regions (2022-2027) 2.3 Antibiotics Active Pharmaceutical Ingredient Industry Dynamic 2.3.1 Antibiotics Active Pharmaceutical Ingredient Market Trends 2.3.2 Antibiotics Active Pharmaceutical Ingredient Market Drivers 2.3.3 Antibiotics Active Pharmaceutical Ingredient Market Challenges 2.3.4 Antibiotics Active Pharmaceutical Ingredient Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue 3.1.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue (2016-2021) 3.1.2 Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Players (2016-2021) 3.2 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antibiotics Active Pharmaceutical Ingredient Revenue 3.4 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio 3.4.1 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020 3.5 Antibiotics Active Pharmaceutical Ingredient Key Players Head office and Area Served 3.6 Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service 3.7 Date of Enter into Antibiotics Active Pharmaceutical Ingredient Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Type 4.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Type (2016-2021) 4.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027) 5 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Application 5.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Application (2016-2021) 5.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027) 6.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type 6.2.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 6.2.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) 6.2.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027) 6.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application 6.3.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 6.3.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) 6.3.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027) 6.4 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country 6.4.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) 6.4.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027) 7.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type 7.2.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 7.2.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) 7.2.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027) 7.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application 7.3.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 7.3.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) 7.3.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027) 7.4 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country 7.4.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) 7.4.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027) 8.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type 8.2.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027) 8.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application 8.3.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027) 8.4 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region 8.4.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027) 9.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type 9.2.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 9.2.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) 9.2.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027) 9.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application 9.3.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 9.3.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) 9.3.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027) 9.4 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country 9.4.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) 9.4.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027) 10.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type 10.2.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027) 10.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application 10.3.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027) 10.4 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country 10.4.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sandoz International 11.1.1 Sandoz International Company Details 11.1.2 Sandoz International Business Overview 11.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient Introduction 11.1.4 Sandoz International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.1.5 Sandoz International Recent Development 11.2 Centrient Pharmaceuticals 11.2.1 Centrient Pharmaceuticals Company Details 11.2.2 Centrient Pharmaceuticals Business Overview 11.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Introduction 11.2.4 Centrient Pharmaceuticals Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.2.5 Centrient Pharmaceuticals Recent Development 11.3 CordenPharma International 11.3.1 CordenPharma International Company Details 11.3.2 CordenPharma International Business Overview 11.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Introduction 11.3.4 CordenPharma International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.3.5 CordenPharma International Recent Development 11.4 ACS DOBFAR 11.4.1 ACS DOBFAR Company Details 11.4.2 ACS DOBFAR Business Overview 11.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Introduction 11.4.4 ACS DOBFAR Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.4.5 ACS DOBFAR Recent Development 11.5 Nanjing Dorra Pharmaceutical Technology 11.5.1 Nanjing Dorra Pharmaceutical Technology Company Details 11.5.2 Nanjing Dorra Pharmaceutical Technology Business Overview 11.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Introduction 11.5.4 Nanjing Dorra Pharmaceutical Technology Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.5.5 Nanjing Dorra Pharmaceutical Technology Recent Development 11.6 DAEWOONG PHARMACEUTICAL 11.6.1 DAEWOONG PHARMACEUTICAL Company Details 11.6.2 DAEWOONG PHARMACEUTICAL Business Overview 11.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Introduction 11.6.4 DAEWOONG PHARMACEUTICAL Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.6.5 DAEWOONG PHARMACEUTICAL Recent Development 11.7 Parabolic Drugs 11.7.1 Parabolic Drugs Company Details 11.7.2 Parabolic Drugs Business Overview 11.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Introduction 11.7.4 Parabolic Drugs Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.7.5 Parabolic Drugs Recent Development 11.8 Penam Laboratories 11.8.1 Penam Laboratories Company Details 11.8.2 Penam Laboratories Business Overview 11.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Introduction 11.8.4 Penam Laboratories Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.8.5 Penam Laboratories Recent Development 11.9 ASIATIC DRUGS & PHARMACEUTICALS 11.9.1 ASIATIC DRUGS & PHARMACEUTICALS Company Details 11.9.2 ASIATIC DRUGS & PHARMACEUTICALS Business Overview 11.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Introduction 11.9.4 ASIATIC DRUGS & PHARMACEUTICALS Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Development 11.10 Fresenius Kabi 11.10.1 Fresenius Kabi Company Details 11.10.2 Fresenius Kabi Business Overview 11.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Introduction 11.10.4 Fresenius Kabi Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.10.5 Fresenius Kabi Recent Development 11.11 The United Laboratories International Holdings 11.11.1 The United Laboratories International Holdings Company Details 11.11.2 The United Laboratories International Holdings Business Overview 11.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Introduction 11.11.4 The United Laboratories International Holdings Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.11.5 The United Laboratories International Holdings Recent Development 11.12 Aurobindo Pharma Limited 11.12.1 Aurobindo Pharma Limited Company Details 11.12.2 Aurobindo Pharma Limited Business Overview 11.12.3 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Introduction 11.12.4 Aurobindo Pharma Limited Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.12.5 Aurobindo Pharma Limited Recent Development 11.13 Unimark Remedies 11.13.1 Unimark Remedies Company Details 11.13.2 Unimark Remedies Business Overview 11.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Introduction 11.13.4 Unimark Remedies Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.13.5 Unimark Remedies Recent Development 11.14 Savior Lifetec 11.14.1 Savior Lifetec Company Details 11.14.2 Savior Lifetec Business Overview 11.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Introduction 11.14.4 Savior Lifetec Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) 11.14.5 Savior Lifetec Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Penicillin Antibiotics Table 3. Key Players of Cephalosporins Table 4. Key Players of Carbapenem Antibiotics Table 5. Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2016-2021) Table 9. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2022-2027) Table 11. Antibiotics Active Pharmaceutical Ingredient Market Trends Table 12. Antibiotics Active Pharmaceutical Ingredient Market Drivers Table 13. Antibiotics Active Pharmaceutical Ingredient Market Challenges Table 14. Antibiotics Active Pharmaceutical Ingredient Market Restraints Table 15. Global Antibiotics Active Pharmaceutical Ingredient Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Players (2016-2021) Table 17. Global Top Antibiotics Active Pharmaceutical Ingredient Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient as of 2020) Table 18. Ranking of Global Top Antibiotics Active Pharmaceutical Ingredient Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Antibiotics Active Pharmaceutical Ingredient Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service Table 22. Date of Enter into Antibiotics Active Pharmaceutical Ingredient Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 25. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) Table 26. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Antibiotics Active Pharmaceutical Ingredient Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021) Table 30. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 33. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million) Table 35. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million) Table 62. Sandoz International Company Details Table 63. Sandoz International Business Overview Table 64. Sandoz International Antibiotics Active Pharmaceutical Ingredient Product Table 65. Sandoz International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 66. Sandoz International Recent Development Table 67. Centrient Pharmaceuticals Company Details Table 68. Centrient Pharmaceuticals Business Overview Table 69. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Product Table 70. Centrient Pharmaceuticals Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 71. Centrient Pharmaceuticals Recent Development Table 72. CordenPharma International Company Details Table 73. CordenPharma International Business Overview Table 74. CordenPharma International Antibiotics Active Pharmaceutical Ingredient Product Table 75. CordenPharma International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 76. CordenPharma International Recent Development Table 77. ACS DOBFAR Company Details Table 78. ACS DOBFAR Business Overview Table 79. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Product Table 80. ACS DOBFAR Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 81. ACS DOBFAR Recent Development Table 82. Nanjing Dorra Pharmaceutical Technology Company Details Table 83. Nanjing Dorra Pharmaceutical Technology Business Overview Table 84. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Product Table 85. Nanjing Dorra Pharmaceutical Technology Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 86. Nanjing Dorra Pharmaceutical Technology Recent Development Table 87. DAEWOONG PHARMACEUTICAL Company Details Table 88. DAEWOONG PHARMACEUTICAL Business Overview Table 89. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Product Table 90. DAEWOONG PHARMACEUTICAL Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 91. DAEWOONG PHARMACEUTICAL Recent Development Table 92. Parabolic Drugs Company Details Table 93. Parabolic Drugs Business Overview Table 94. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Product Table 95. Parabolic Drugs Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 96. Parabolic Drugs Recent Development Table 97. Penam Laboratories Company Details Table 98. Penam Laboratories Business Overview Table 99. Penam Laboratories Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 100. Penam Laboratories Recent Development Table 101. ASIATIC DRUGS & PHARMACEUTICALS Company Details Table 102. ASIATIC DRUGS & PHARMACEUTICALS Business Overview Table 103. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Product Table 104. ASIATIC DRUGS & PHARMACEUTICALS Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 105. ASIATIC DRUGS & PHARMACEUTICALS Recent Development Table 106. Fresenius Kabi Company Details Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Product Table 109. Fresenius Kabi Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 110. Fresenius Kabi Recent Development Table 111. The United Laboratories International Holdings Company Details Table 112. The United Laboratories International Holdings Business Overview Table 113. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Product Table 114. The United Laboratories International Holdings Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 115. The United Laboratories International Holdings Recent Development Table 116. Aurobindo Pharma Limited Company Details Table 117. Aurobindo Pharma Limited Business Overview Table 118. Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Product Table 119. Aurobindo Pharma Limited Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 120. Aurobindo Pharma Limited Recent Development Table 121. Unimark Remedies Company Details Table 122. Unimark Remedies Business Overview Table 123. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Product Table 124. Unimark Remedies Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 125. Unimark Remedies Recent Development Table 126. Savior Lifetec Company Details Table 127. Savior Lifetec Business Overview Table 128. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Product Table 129. Savior Lifetec Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million) Table 130. Savior Lifetec Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Type: 2020 VS 2027 Figure 2. Penicillin Antibiotics Features Figure 3. Cephalosporins Features Figure 4. Carbapenem Antibiotics Features Figure 5. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Application: 2020 VS 2027 Figure 6. Pharmaceutical Companies Case Studies Figure 7. Contract Manufacturing Organizations (CMOs) Case Studies Figure 8. Contract Development & Manufacturing Organizations (CDMOs) Case Studies Figure 9. Antibiotics Active Pharmaceutical Ingredient Report Years Considered Figure 10. Global Antibiotics Active Pharmaceutical Ingredient Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Antibiotics Active Pharmaceutical Ingredient Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions: 2020 VS 2027 Figure 13. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2022-2027) Figure 14. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Players in 2020 Figure 15. Global Top Antibiotics Active Pharmaceutical Ingredient Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020 Figure 17. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) Figure 18. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2022-2027) Figure 19. North America Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027) Figure 21. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027) Figure 22. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027) Figure 23. United States Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027) Figure 27. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027) Figure 28. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027) Figure 29. Germany Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027) Figure 37. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027) Figure 38. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Region (2016-2027) Figure 39. China Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027) Figure 47. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027) Figure 48. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027) Figure 49. Mexico Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027) Figure 53. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027) Figure 54. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027) Figure 55. Turkey Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Sandoz International Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 59. Centrient Pharmaceuticals Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 60. CordenPharma International Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 61. ACS DOBFAR Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 62. Nanjing Dorra Pharmaceutical Technology Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 63. DAEWOONG PHARMACEUTICAL Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 64. Parabolic Drugs Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 65. Penam Laboratories Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 66. ASIATIC DRUGS & PHARMACEUTICALS Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 67. Fresenius Kabi Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 68. The United Laboratories International Holdings Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 69. Aurobindo Pharma Limited Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 70. Unimark Remedies Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 71. Savior Lifetec Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Sandoz International Centrient Pharmaceuticals CordenPharma International ACS DOBFAR Nanjing Dorra Pharmaceutical Technology DAEWOONG PHARMACEUTICAL Parabolic Drugs Penam Laboratories ASIATIC DRUGS & PHARMACEUTICALS Fresenius Kabi The United Laboratories International Holdings Aurobindo Pharma Limited Unimark Remedies Savior Lifetec